Weekly Investment Analysts’ Ratings Changes for Merit Medical Systems (MMSI)

Merit Medical Systems (NASDAQ: MMSI) recently received a number of ratings updates from brokerages and research firms:

• 8/13/2026 – Merit Medical Systems had its price target raised by Bank of America Corporation from $92.00 to $97.00. They now have a “neutral” rating on the stock.
• 8/11/2026 – Merit Medical Systems had its “buy” rating reaffirmed by BTIG Research. They now have a $105.00 price target on the stock.
• 8/3/2026 – Merit Medical Systems was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
• 7/31/2026 – Merit Medical Systems was given a new $114.00 price target by Barrington Research.
• 7/31/2026 – Merit Medical Systems had its price target raised by Canaccord Genuity Group Inc. from $85.00 to $94.00. They now have a “buy” rating on the stock.
• 7/31/2026 – Merit Medical Systems had its “outperform” rating reaffirmed by Raymond James Financial, Inc.. They now have a $100.00 price target on the stock.
• 7/31/2026 – Merit Medical Systems had its price target raised by Piper Sandler from $96.00 to $106.00. They now have an “overweight” rating on the stock.
• 7/31/2026 – Merit Medical Systems was given a new $98.00 price target by Robert W. Baird.
• 7/31/2026 – Merit Medical Systems had its price target raised by JPMorgan Chase & Co. from $77.00 to $95.00. They now have an “overweight” rating on the stock.
• 7/31/2026 – Merit Medical Systems had its price target raised by Wells Fargo & Company from $74.00 to $83.00. They now have an “equal weight” rating on the stock.
• 7/31/2026 – Merit Medical Systems had its price target raised by BTIG Research from $100.00 to $105.00. They now have a “buy” rating on the stock.
• 7/31/2026 – Merit Medical Systems had its price target raised by Needham & Company LLC from $90.00 to $101.00. They now have a “buy” rating on the stock.
• 7/10/2026 – Merit Medical Systems had its “overweight” rating reaffirmed by Piper Sandler.

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.